Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference

Christopher McCudden, Amy E. Axel, Dominique Slaets, Thomas Dejoie, Pamela L. Clemens, Sandy Frans, Jaime Bald, Torben Plesner, Joannes F. M. Jacobs, Niels W. C. J. van de Donk, Philippe Moreau, Jordan M. Schecter, Tahamtan Ahmadi, A. Kate Sasser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1095-1104
JournalClinical Chemistry and Laboratory Medicine
Volume54
Issue number6
DOIs
Publication statusPublished - Jun 2016

Cite this

McCudden, C., Axel, A. E., Slaets, D., Dejoie, T., Clemens, P. L., Frans, S., ... Sasser, A. K. (2016). Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference. Clinical Chemistry and Laboratory Medicine, 54(6), 1095-1104. https://doi.org/10.1515/cclm-2015-1031